MEDI — Medistim ASA Cashflow Statement
0.000.00%
Last trade - 00:00
- NOK3.51bn
- NOK3.37bn
- NOK526.36m
- 98
- 14
- 17
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 70.3 | 69.4 | 90.9 | 114 | 135 |
Depreciation | |||||
Changes in Working Capital | -7.94 | -18.4 | 13.8 | -23.8 | -45.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 80.4 | 74.1 | 128 | 113 | 113 |
Capital Expenditures | -13.7 | — | -7.4 | -9.25 | -16.4 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | -10.6 | -4.08 | -11.9 | -13.3 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -13.7 | -10.6 | -11.5 | -21.1 | -29.7 |
Financing Cash Flow Items | 2.8 | 1.39 | 7.59 | 5.4 | 6.01 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -46.9 | -58.3 | -59.1 | -70.3 | -84.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 19.3 | 5.15 | 57.6 | 23.2 | 1.23 |